세계의 문합기 시장(2024-2031년)

Anastomosis Devices Market Size, Share & Trends Analysis Report by Product (Disposable, and Reusable), by Application (Cardiovascular Surgery, Gastrointestinal Surgery, and Others), by End-User (Hospitals, Ambulatory Care Centers, and Clinics) Forecast Period (2024-2031)

Anastomosis devices market is anticipated to grow at a CAGR of 5.2% during the forecast period (2024-2031). The increasing prevalence of chronic diseases and technological advancements drives the demand for anastomosis devices. Additionally, the rising healthcare expenditure in developing countries and improved medical infrastructure contribute to market growth.

Market Dynamics

Rising Incidence of Chronic Diseases

The increasing occurrence of chronic diseases necessitates the use of anastomosis devices during surgical procedures, such as coronary artery bypass grafting (CABG) for heart disease. According to the National Center for Chronic Disease Prevention and Health Promotion, in February 2024, a significant number of individuals in the US, approximately 129 million, are affected by major chronic diseases, such as heart disease, cancer, diabetes, obesity, and hypertension. Moreover, preventable and treatable chronic diseases are among the leading causes of mortalities in the country, contributing to an estimated five out of the top ten causes. This trend of increasing prevalence has persisted over the past two decades and is projected to continue, with a growing proportion of Americans experiencing multiple chronic conditions. In addition to the personal influence, the management and treatment of chronic diseases and mental health conditions account for around 90.0% of the annual $4.1 trillion expenditure on healthcare in the US.

Increased Surgical Procedures

Increased surgical procedures have created a demand for surgical hubs. According to the Department of Health and Social Care, in August 2022, the addition of over 50 new surgical hubs significantly increased demand for anastomosis devices. The government has allocated £1.5 billion in funding to support this initiative, with projections indicating that nearly 2 million additional routine operations will be performed over the next three years.

Market Segmentation

• Based on product, the market is segmented into reusable, and disposable.
• Based on end-users, the market is segmented into hospitals, ambulatory care centers, and clinics.
• Based on application, the market is segmented into cardiovascular surgery, gastrointestinal surgery, and others (vascular procedures).

Cardiovascular Surgery is Projected to Emerge as the Largest Segment

The primary factor supporting the segment's growth includes the demand for treatments such as CABG and vascular reconstructions, that demand for the use of anastomosis devices. According to the World Heart Federation, in 2023, cardiovascular diseases have a significant influence globally, with over half a billion individuals affected and 20.5 million mortalities recorded in 2021. This accounts for approximately one-third of all global mortalities. While advances in cardiovascular medicine have shown potential in preventing up to 80.0% of premature heart attacks and strokes, it is crucial to address the existing health inequity, as progress in cardiovascular health remains concentrated in high-income countries.

Regional Outlook

The global anastomosis devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

North America Holds Major Market Share

The rising rate of cancer renders anastomosis devices essential for procedures such as tumor excision and organ removal to reconnect blood arteries or organs driving the demand for regional markets. According to the National Cancer Institute, in May 2024, the US is expected to see 2 million new cancer cases and 611,720 mortalities. Common cancers include breast, prostate, lung, colon, rectum, skin, bladder, kidney, renal pelvis, non-Hodgkin lymphoma, endometrial, pancreatic, leukemia, thyroid, and liver cancer. The cancer incidence is 440.5 per 100,000 men and women per year, with a higher mortality rate among men. Non-Hispanic Black men have the highest cancer mortality rate. As of January 2022, there were 18.1 million cancer survivors, with a projected increase to 22.5 million by 2032.

Market Players Outlook

The major companies serving the global anastomosis devices market include B. Braun Melsungen, Intuitive Surgical Inc., Baxter International Inc. (Synovis Micro Companies Alliance, Inc.), Medtronic Plc, and Johnson & Johnson (Ethicon US, LLC) among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions to stay competitive in the market. For instance, in June 2022, Ethicon, part of Johnson & Johnson MedTech, launched the ECHELON 3000 Stapler in the US, a digitally enabled device that offers surgeons one-handed powered articulation, improved access, control, and real-time feedback for critical adjustments.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Market Trends
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. B. Braun Melsungen
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. Intuitive Surgical Inc.
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. Medtronic Plc
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Anastomosis Devices Market by Product
  • 4.1.1. Reusable
  • 4.1.2. Disposable
• 4.2. Global Anastomosis Devices Market by End-User
  • 4.2.1. Hospitals
  • 4.2.2. Ambulatory Care Centers and Clinics
• 4.3. Global Anastomosis Devices Market by Application
  • 4.3.1. Cardiovascular Surgery
  • 4.3.2. Gastrointestinal Surgery
  • 4.3.3. Others (Vascular Procedures)

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World
  • 5.4.1. Latin America
  • 5.4.2. Middle East & Africa

6. Company Profiles

• 6.1. Artivion Inc.
• 6.2. Baxter International Inc. (Synovis Micro Companies Alliance, Inc.)
• 6.3. Becton, Dickinson and Company
• 6.4. Boston Scientific Corp.
• 6.5. Carponovum AB
• 6.6. ETHICON, Inc. (Johnson & Johnson Services, Inc.)
• 6.7. Getinge AB
• 6.8. LivaNova Plc
• 6.9. Medline Industries, LP
• 6.10. Meril Lifesciences Pvt. Ltd.
• 6.11. Mizuho Medical Co., Ltd (MIZUHO Corporation)
• 6.12. Peters Surgical Solutions Ltd.
• 6.13. Seger Surgical Solutions Ltd.
• 6.14. Vascular Graft Solutions Ltd.